TYRA - Tyra Biosciences Inc
Tyra Biosciences Inc Logo

TYRA - Tyra Biosciences Inc

https://tyra.bio
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
Bearish
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Celcuity ( NASDAQ:CELC ) , GrafTech International ( NYSE:EAF )
Benzinga • 8 months, 1 week ago • score: -0.57
U.S. stock futures were higher this morning, with the Dow futures gaining more than 300 points on Thursday. Shares of Neumora Therapeutics, Inc. NMRA fell sharply in today's pre-market trading after the company reported data from KOASTAL-1 study of Navacaprant in major depressive disorder.
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-09 (Snapshot)

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and improve outcomes for cancer patients. The company is headquartered in Carlsbad, California.

52W High
$29.60
52W Low
$6.42
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
1.10
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-6.95
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
2.23
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
3.68%
Institutions (25–75% balanced)
108.51%
Shares Outstanding
53,297,000
Float
17,219,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-1.79
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.31%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.6131
Previous
0.5997
Trend
Rising
Signal Cross
No cross
As of
Sep. 05, 2025